Skip to main content

Kiniksa Pharmaceuticals International, plc

KNSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001730430

In the last 90 days, Kiniksa Pharmaceuticals International, plc insiders filed 0 open-market purchases and 2 sales; 267 institutions reported holding it in 13F filings for Q2 2026, worth $2.99B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Kiniksa Pharmaceuticals International, plc changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of KNSA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders189204+15
Shares39.9M40.8M+989.0K (+2.5%)
Value$1.10B$1.59B+$483.0M (+43.8%)

New holders (47)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to KNSA in Q3 2025
InstitutionSharesValue% of portfolio
Nomura Holdings Inc397,139$15.4M0.07%
Rockefeller Capital Management L.P.173,438$6.73M0.01%
Standard Life Aberdeen plc158,722$6.16M0.01%
Castleark Management LLC158,632$6.16M0.17%
Silvercrest Asset Management Group LLC126,260$4.90M0.03%
Voleon Capital Management LP89,166$3.46M0.08%
Man Group plc67,905$2.64M0.01%
Adage Capital Partners GP, L.L.C.59,000$2.29M0.00%
Campbell & CO Investment Adviser LLC38,117$1.48M0.11%
Nuveen, LLC20,233$785.6K0.00%
Sheets Smith Investment Management16,992$659.8K0.43%
Mark Sheptoff Financial Planning, LLC16,100$625.2K0.30%
Quantedge Capital Pte Ltd15,045$584.2K0.32%
Prosperity Wealth Management, Inc.13,900$539.7K0.18%
Kingsview Wealth Management, LLC9,941$386.0K0.01%
Baader Bank INC9,040$351.0K0.03%
Brinker Capital Investments, LLC8,808$342.0K0.00%
State of Wyoming7,962$309.2K0.04%
HSBC Holdings PLC8,080$308.1K0.00%
Sheets Smith Wealth Management7,162$278.1K0.03%
James Investment Research Inc7,027$272.9K0.03%
Juncture Wealth Strategies, LLC6,864$266.5K0.09%
Bryce Point Capital, LLC6,831$265.2K0.32%
PharVision Advisers, LLC6,722$261.0K0.15%
Graham Capital Management, L.P.6,594$256.0K0.01%
Bailard, Inc.5,854$227.3K0.00%
Omers Administration Corp5,800$225.2K0.00%
Savant Capital, LLC5,747$223.2K0.00%
Vestcor Inc5,623$218.0K0.01%
MML Investors Services, LLC5,216$202.5K0.00%
Roman Butler Fullerton & Co5,388$201.4K0.05%
Round Rock Advisors, LLC5,156$200.5K0.03%
SRS Capital Advisors, Inc.4,009$155.7K0.00%
Oregon Public Employees Retirement Fund2,324$90.2K0.00%
State of Alaska, Department of Revenue2,268$88.0K0.00%
Quarry LP1,126$43.7K0.01%
USA Financial Portformulas Corp816$31.7K0.01%
Federation des caisses Desjardins du Quebec500$19.4K0.00%
Larson Financial Group LLC337$13.1K0.00%
Rothschild Investment LLC150$5.83K0.00%
Marquette Asset Management, LLC61$2.37K0.00%
Sunbelt Securities, Inc.42$1.63K0.00%
Optiver Holding B.V.26$1.01K0.00%
Stone House Investment Management, LLC22$8540.00%
Root Financial Partners, LLC8$3110.00%
Assetmark, Inc5$1940.00%
Harbour Investments, Inc.3$1160.00%

Sold out (32)

Institutions that held Kiniksa Pharmaceuticals International, plc at the end of Q2 2025 and filed for Q3 2025 without it.